Skip to main content


Page 2 of 5

  1. The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention, with speculation that CBD can be useful in a wide range of conditions. Only one product, a purified form of plant-deri...

    Authors: Saoirse Elizabeth O’Sullivan, Sanne Skov Jensen, Gitte Nykjaer Nikolajsen, Heidi Ziegler Bruun, Rhenu Bhuller and Julia Hoeng
    Citation: Journal of Cannabis Research 2023 5:21
  2. The aim of the current study was to examine patterns of medical cannabis use in those using it to treat anxiety and to investigate if the anxiolytic effects of cannabis were impacted by gender and/or age.

    Authors: Meenu Minhas and Stephanie E. Lunn
    Citation: Journal of Cannabis Research 2023 5:20
  3. This paper examines the factors that led to the collapse of hemp grown for cannabidiol (CBD) in Arizona, the United States of America (USA), and particularly in Yuma County, which is a well-established agricul...

    Authors: Anastasia K. Stats, Ken G. Sweat, Robert N. Masson, Kendra D. Conrow, Amy E. Frazier and Maxwell C. K. Leung
    Citation: Journal of Cannabis Research 2023 5:19
  4. Throughout the past two decades of legal medical cannabis in Canada, individuals have experienced challenges related to accessing legal sources of cannabis for medical purposes. The objective of our study was ...

    Authors: N. Rielle Capler, Lynda G. Balneaves, Jane A. Buxton and Thomas Kerr
    Citation: Journal of Cannabis Research 2023 5:18
  5. The reintroduction of Cannabis sativa L. in the form of hemp (< 0.3% THC by dry weight) into the US agricultural sector has been complex and remains confounded by its association with cannabis (> 0.3% THC by dry ...

    Authors: Amanda Falkner, Jane Kolodinsky, Tyler Mark, William Snell, Rebecca Hill, Amelia Luke, Jonathan Shepherd and Hannah Lacasse
    Citation: Journal of Cannabis Research 2023 5:17
  6. Understanding the genome of Cannabis sativa holds significant scientific value due to the multi-faceted therapeutic nature of the plant. Links from cannabis gene to therapeutic property are important to establish...

    Authors: Trever J. Jackson and Sunandan Chakraborty
    Citation: Journal of Cannabis Research 2023 5:16
  7. There is an expanding unregulated market for a psychotropic compound called ∆8-Tetrahydrocannabinol (delta-8-THC) that is being derived from hemp, but a summary of adverse events related to delta-8-THC has not be...

    Authors: Eric C. Leas, Raquel M. Harati, Nora Satybaldiyeva, Nicolas E. Morales, Shelby L. Huffaker, Tomas Mejorado and Igor Grant
    Citation: Journal of Cannabis Research 2023 5:15
  8. Cannabis sativa L. also known as industrial hemp, is primarily cultivated as source material for cannabinoids cannabidiol (CBD) and ∆9-tetrahydrocannabinol (∆9-THC). Pesticide contamination during plant growth is...

    Authors: Jamie Cuchiaro, James Baumgartner and Melissa M. Reynolds
    Citation: Journal of Cannabis Research 2023 5:13
  9. Glandular capitate trichomes which form on bract tissues of female inflorescences of high THC-containing Cannabis sativa L. plants are important sources of terpenes and cannabinoids. The influence of plant age an...

    Authors: Zamir K. Punja, Darren B. Sutton and Tommy Kim
    Citation: Journal of Cannabis Research 2023 5:12
  10. Cannabidiol (CBD) is a potential therapeutic for pain management. Yet, there exists a dearth of studies of its tolerability and efficacy, especially in special populations. Former elite athletes are a special ...

    Authors: Nicole Hall, Bradie James, Mohammad Alfrad Nobel Bhuiyan, Erin Crane, Carlie Falgout and Kevin Sean Murnane
    Citation: Journal of Cannabis Research 2023 5:11
  11. The COVID-19 pandemic disrupted health care but it is unknown how it impacted the lives of people using medical cannabis for chronic pain.

    Authors: Yuval Zolotov, Jacinta Lomba, Megan Ghiroli, Mariya Masyukova, Julia H. Arnsten, Joanna L. Starrels, Jonathan Ross, Chinazo O. Cunningham and Deepika E. Slawek
    Citation: Journal of Cannabis Research 2023 5:10
  12. Delta-8 tetrahydrocannabinol (THC) is a psychoactive cannabinoid from the cannabis plant that can be synthetically converted from cannabidiol (CBD). Most states permit the full or restricted sale of hemp and h...

    Authors: Erin K. Bradley, Brooke E. Hoots, Evan S. Bradley and Douglas R. Roehler
    Citation: Journal of Cannabis Research 2023 5:9
  13. Investigation of cannabis use trends among emerging adults (EA, aged between 18 and 24 years) following 2018 Canadian Recreational Cannabis Legislation (RCL) is critical. EAs report the heaviest cannabis use i...

    Authors: N’deye Rokhaya Gueye, Kevin Prada and Danielle de Moissac
    Citation: Journal of Cannabis Research 2023 5:8
  14. With the legalization of cannabis in multiple jurisdictions throughout the world, a larger proportion of the population consumes cannabis. Several studies have demonstrated anti-tumor effects of components pre...

    Authors: Erin G. Whynot, Andrea M. Tomko and Denis J. Dupré
    Citation: Journal of Cannabis Research 2023 5:7
  15. Cannabidiol (CBD) extracted from the cannabis plant is believed to have a medicinal value due to its neuroprotective effect via anti-inflammatory and antioxidant action. Recent behavioral studies in rats have ...

    Authors: Akihiro Hasumi and Hideyuki Maeda
    Citation: Journal of Cannabis Research 2023 5:6
  16. Hemp and marijuana are the two major varieties of Cannabis sativa. While both contain Δ9-tetrahydrocannabinol (THC), the primary psychoactive component of C. sativa, they differ in the amount of THC that they con...

    Authors: Megan I. Chambers, Samira Beyramysoltan, Benedetta Garosi and Rabi A. Musah
    Citation: Journal of Cannabis Research 2023 5:5
  17. Little is known about the frequency with which different combinations of phytochemicals (chemovars) arise in Cannabis flower or whether common chemovars are associated with distinct pharmacodynamics and patient h...

    Authors: Jacob Miguel Vigil, Sarah See Stith, Franco Brockelman, Keenan Keeling and Branden Hall
    Citation: Journal of Cannabis Research 2023 5:4
  18. Comparative bioavailability of cannabinoids following their administration by dosing routes has been studied previously, but there are no quantitative reports of distribution of Δ9THC, nor its metabolites, across...

    Authors: Gunjan Upadhyay, Oksana Fihurka, Connor Habecker, Pranav Patel and Juan Sanchez-Ramos
    Citation: Journal of Cannabis Research 2023 5:3
  19. The purpose of this study was to examine the perceived influence of cannabis on sexual functioning and satisfaction. This study used Kaplan’s and Masters and Johnson’s sexual response cycle (desire, excitement...

    Authors: Amanda Moser, Sharon M. Ballard, Jake Jensen and Paige Averett
    Citation: Journal of Cannabis Research 2023 5:2
  20. Although the chemical constituents of the aerial parts of Cannabis have been extensively studied, phytochemicals of Cannabis roots are not well characterized. Herein, we investigated the chemical constituents of ...

    Authors: Shijie Huang, Huifang Li, Jun Xu, Huihao Zhou, Navindra P. Seeram, Hang Ma and Qiong Gu
    Citation: Journal of Cannabis Research 2023 5:1
  21. Cannabis sativa is a primarily dioecious angiosperm that exhibits sexual developmental plasticity. Developmental genes for staminate male flowers have yet to be elucidated; however, there are regions of male-asso...

    Authors: Anthony Torres, Christopher Pauli, Robert Givens, Jason Argyris, Keith Allen, Amparo Monfort and Reginald J. Gaudino
    Citation: Journal of Cannabis Research 2022 4:57
  22. In the UK, legislation and regulations governing medical cannabis and over the counter cannabidiol (CBD) wellness products have rapidly evolved since 2018. This study aimed to assess the public awareness of th...

    Authors: Simon Erridge, Ross Coomber and Mikael H Sodergren
    Citation: Journal of Cannabis Research 2022 4:56
  23. Although the worldwide use of medical cannabis (MC) is on the rise, there is insufficient data regarding the long-term stability of phytocannabinoids in the plant material under different storage conditions. S...

    Authors: Joshua Aviram, Daniella Atzmony, Anna Frenklakh, Asaf Kroll, Ilana Zaks and Arno Hazekamp
    Citation: Journal of Cannabis Research 2022 4:55
  24. Endometriosis patients experience debilitating chronic pain, and the first-line treatment is ineffective at managing symptoms. Although surgical removal of the lesions provides temporary relief, more than 50% ...

    Authors: Harshavardhan Lingegowda, Bailey J. Williams, Katherine G. Spiess, Danielle J. Sisnett, Alan E. Lomax, Madhuri Koti and Chandrakant Tayade
    Citation: Journal of Cannabis Research 2022 4:54
  25. The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage ...

    Authors: Monique van Es-Remers, Jesus Arellano Spadaro, Eefje Poppelaars, Hye Kyong Kim, Marieke van Haaster, Marcel de Wit, Eva ILiopoulou, Marjolein Wildwater and Henrie Korthout
    Citation: Journal of Cannabis Research 2022 4:53
  26. Hemp (Cannabis sativa L.) is a producer of cannabinoids. These organic compounds are of increasing interest due to their potential applications in the medicinal field. Advances in analytical methods of identifyin...

    Authors: Luca De Prato, Matthew Timmins, Omid Ansari, Katinka X. Ruthrof, Giles E. St. J. Hardy, John Howieson and Graham O’Hara
    Citation: Journal of Cannabis Research 2022 4:51
  27. Use of medical cannabis is increasing among older adults. However, few investigations have examined cannabis use in this population.

    Authors: Laura MacNair, Maja Kalaba, Erica N. Peters, Matthew T. Feldner, Graham M. L. Eglit, Lucile Rapin, Cynthia El Hage, Erin Prosk and Mark A. Ware
    Citation: Journal of Cannabis Research 2022 4:50
  28. Due to the growing use of cannabis for the purposes of pain relief, evidence is needed on the impact of cannabis use on concurrent analgesic use. Therefore, our objective was to evaluate the association betwee...

    Authors: Ria Garg, Kam Shojania and Mary A. De Vera
    Citation: Journal of Cannabis Research 2022 4:49
  29. Few studies have evaluated weight change in patients who initiate medical marijuana treatment to address diagnosed health concerns. The objective of this study was to examine whether patients initiating medica...

    Authors: Michelle R. Lent, Meghan Visek, Paulina Syracuse, Karen L. Dugosh and David S. Festinger
    Citation: Journal of Cannabis Research 2022 4:48
  30. An estimated 54 million Americans currently suffer from debilitating arthritis. Patients who have exhausted conservative measures can be subject to chronic pain and resort to symptomatic management with anti-i...

    Authors: Nicholas Frane, Erik Stapleton, Cesar Iturriaga, Maximillian Ganz, Vijay Rasquinha and Robert Duarte
    Citation: Journal of Cannabis Research 2022 4:47
  31. While cannabis is known to have immunomodulatory properties, the clinical consequences of its use on outcomes in COVID-19 have not been extensively evaluated. We aimed to assess whether cannabis users hospital...

    Authors: Carolyn M. Shover, Peter Yan, Nicholas J. Jackson, Russell G. Buhr, Jennifer A. Fulcher, Donald P. Tashkin and Igor Barjaktarevic
    Citation: Journal of Cannabis Research 2022 4:46
  32. Industrial hemp, with low levels of the intoxicating cannabinoid tetrahydrocannabinol (THC), is grown for fibre and seeds. The industrial hemp industry is poised for expansion. The legalisation of industrial h...

    Authors: Rachel A. Burton, Mike Andres, Martin Cole, James M. Cowley and Mary Ann Augustin
    Citation: Journal of Cannabis Research 2022 4:45
  33. Cannabinol (CBN) is one of the many cannabinoids present in Cannabis sativa and has been explored as a potential treatment for sleeplessness. The purpose of this study was to determine the physiological and behav...

    Authors: Melissa M. Bailey, Mariah C. Emily Mills, Ashley E. Haas, Kelly Bailey and Robert C. Kaufmann
    Citation: Journal of Cannabis Research 2022 4:44
  34. In 2019, Thailand legalized cannabidiol (CBD) for intractable epilepsy. The purpose of this study was to collect information regarding the experience and knowledge of CBD use in pediatric epilepsy. To the best...

    Authors: Monsicha Ngampoopun, Charcrin Nabangchang and Piradee Suwanpakdee
    Citation: Journal of Cannabis Research 2022 4:43
  35. Several studies have shown anti-tumor effects of components present in cannabis in different models. Unfortunately, little is known about the potential anti-tumoral effects of most compounds present in cannabi...

    Authors: Andrea M. Tomko, Erin G. Whynot and Denis J. Dupré
    Citation: Journal of Cannabis Research 2022 4:41
  36. The purpose of this study is to examine how cannabis legalization and corresponding taxation would affect the supply-side of the cannabis market. Specifically, the study considers various scenarios in which Ok...

    Authors: Joohun Han and John N. Ng’ombe
    Citation: Journal of Cannabis Research 2022 4:40
  37. There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for a few indications, there is a hype about...

    Authors: Arthur Cassa Macedo, André Oliveira Vilela de Faria, Isabella Bizzi, Fabrício A. Moreira, Alessandro Colasanti and Pietro Ghezzi
    Citation: Journal of Cannabis Research 2022 4:37
  38. As a result of the legalization of U.S. industrial hemp production in late 2018, products containing hemp-derived Δ8-tetrahydrocannabinol (Δ8-THC) are increasing in popularity. Little, however, is known regarding...

    Authors: Gregory T. Wurz, Edward Montoya and Michael W. DeGregorio
    Citation: Journal of Cannabis Research 2022 4:36
  39. For a long period, cannabis in Lebanon was categorized as an illegal psychoactive substance criminalized by law, despite being the 3rd largest producer of cannabis resin after Morocco and Afghanistan. The curr...

    Authors: Anthony Mina, Clara Rahme, Souheil Hallit and Michel Soufia
    Citation: Journal of Cannabis Research 2022 4:34
  40. Cannabis sativa has accompanied humankind since ancient times, permeating the most diverse aspects of its existence, among which the search for health promotion and well-being stands out. Nevertheless, during the...

    Authors: Maíra Ribeiro de Souza, Amélia Teresinha Henriques and Renata Pereira Limberger
    Citation: Journal of Cannabis Research 2022 4:33
  41. Patients use medical cannabis for a wide array of illnesses and symptoms, and many substitute cannabis for pharmaceuticals. This substitution often occurs without physician oversight, raising patient safety co...

    Authors: Alexis Holman, Daniel J. Kruger, Philippe Lucas, Kaye Ong, Rachel S. Bergmans and Kevin F. Boehnke
    Citation: Journal of Cannabis Research 2022 4:32
  42. Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial...

    Authors: Tangui Barré, Fabrice Carrat, Clémence Ramier, Hélène Fontaine, Vincent Di Beo, Morgane Bureau, Céline Dorival, Dominique Larrey, Elisabeth Delarocque-Astagneau, Philippe Mathurin, Fabienne Marcellin, Ventzislava Petrov-Sanchez, Carole Cagnot, Patrizia Carrieri, Stanislas Pol and Camelia Protopopescu
    Citation: Journal of Cannabis Research 2022 4:31
  43. Purified cannabidiol (CBD), a non-psychoactive phytocannabinoid, has gained regulatory approval to treat intractable childhood epilepsies. Despite this, artisanal and commercial CBD-dominant hemp-based product...

    Authors: Carol J. Milligan, Lyndsey L. Anderson, Michael T. Bowen, Samuel D. Banister, Iain S. McGregor, Jonathon C. Arnold and Steven Petrou
    Citation: Journal of Cannabis Research 2022 4:30

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.1
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.894
    SCImago Journal Rank (SJR): 0.692

    Speed 2023
    Submission to first editorial decision (median days): 22
    Submission to acceptance (median days): 211

    Usage 2023
    Downloads: 596,678
    Altmetric mentions: 1,834